Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
The current price of Eli Lilly And Co in the market is ₩1,682,692.72, with a 24-hour trading volume of ₩0. The asset's market cap is ₩1.5P, after moving -1.21% in the last day.
Tokenized Eli Lilly And Co is trading at ₩1,678,454.17, with a tokenized market cap of ₩65.07B and a 24-hour trading volume of ₩3.69B. The tokenized asset has moved 0.17% in the past 24 hours.